Bacterial adherence to surfaces is the determining first step in staphylococcal infections. Activated Specific interaction between Staphylococcus aureus and host ligands is a prerequisite for bacterial adherence, the pivotal step in tissue colonization and infection. Bacterial adherence to fibrin-platelet matrices has been extensively studied in nonbacterial thrombotic endocarditis (for a review, see reference 49). Platelets have been shown to play a major role in this interaction, since adherence of streptococci (47) and staphylococci (9) to an immobilized fibrin matrix is largely increased even in the presence of small numbers of platelets in the matrix. Furthermore, platelets interact avidly with staphylococci and streptococci, resulting in platelet activation and aggregation (10, 11) . However, the components on platelet membranes responsible for the interaction with staphylococci are not yet well defined.
capacity. The binding reaction was insensitive to previous trypsin treatment of bacteria, but it was strongly inhibited in the presence of heparin. Protein A-negative and -positive strains had similar binding characteristics. To determine the promotion of staphylococcal adherence to surfaces by solid-phase thrombospondin, we incubated 3H-labeled S. aureus Cowan 1 and 26 pathogenic staphylococcal isolates with thrombospondincoated polymethylmethacrylate disks and found that adherence was significantly promoted as a function of adsorbed thrombospondin. These results indicate a role for thrombospondin as an important mediator of staphylococcal adherence to activated platelets, to blood clots, or to extracellular matrices in pyogenic infections.
Specific interaction between Staphylococcus aureus and host ligands is a prerequisite for bacterial adherence, the pivotal step in tissue colonization and infection. Bacterial adherence to fibrin-platelet matrices has been extensively studied in nonbacterial thrombotic endocarditis (for a review, see reference 49) . Platelets have been shown to play a major role in this interaction, since adherence of streptococci (47) and staphylococci (9) to an immobilized fibrin matrix is largely increased even in the presence of small numbers of platelets in the matrix. Furthermore, platelets interact avidly with staphylococci and streptococci, resulting in platelet activation and aggregation (10, 11) . However, the components on platelet membranes responsible for the interaction with staphylococci are not yet well defined.
Thrombospondin, a large multifunctional homotrimeric glycoprotein (Mr, 420,000), is the most prevalent glycoprotein stored in a granules of platelets (26) . It is secreted upon stimulation (4) and either bound to the platelet surface (37) through a receptor interaction (1, 3, 54) or released and incorporated into fibrin matrices and blood clots (5, 34 fluid-phase thrombospondin interacts with staphylococci specifically and that thrombospondin adsorbed to a solid phase promotes adherence of staphylococci significantly.
MATERIALS AND METHODS
Chemicals and materials.
[3H]thymidine and carrierfree [125I]sodium iodide were purchased from Amersham (Buckinghamshire, United Kingdom). Ca2+-repleted thrombospondin was purified from the supernatant of thrombinactivated platelets, as previously described (12) . Examination of the purified protein by using 7.5% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (21) (Fig. 1, inset) .
Staphylococcal adherence to thrombospondin-coated PMMA. We modified a previously described adherence assay (52 was increased as a function of thrombospondin concentration in the incubation medium and showed saturable binding characteristics ( Fig. 2A) . These data were analyzed by using the Scatchard equation (45) . The x-axis intercept of the regression line yields the number of thrombospondin molecules bound per bacterium and the slope of the line yields the apparent dissociation constant (Kd). In the presence of Ca2 , Scatchard analysis suggests the presence of two binding sites with different affinities (Fig. 2B) Binding of thrombospondin to S. aureus increased as a function of time. Binding was half-maximal after 30 min of incubation and reached a plateau at 120 min (Fig. 3A) . As the quantity of bacteria was increased, more thrombospondin was bound. A linear relationship between the number of bacteria inoculated and the amount of thrombospondin bound was found with bacterial numbers between 107 and 109 CFU/ml (r = 0.98) (Fig. 3B) .
To determine the specificity of the binding reaction, both inhibition and displacement experiments were performed in the presence of unlabeled thrombospondin and other competitors. For inhibition experiments, S. aureus was pretreated for 30 min with different concentrations of thrombospondin, fibronectin, fibrinogen, or heparin, and subsequently radiolabeled thrombospondin was added for binding. A 100-fold molar excess of unlabeled thrombospondin inhibited the binding to 76.4% ± 11.8% (mean inhibition ± the standard deviation) (Fig. 4A) . Furthermore, binding was inhibited up to 56.8% ± 11.0% and 67.2% ± 31.4% by 100-fold molar excesses of fibronectin and fibrinogen, respectively. To determine the relative potency of these various competitors, the EC50, i.e., the concentration of a competitor that reduces by half the specific radioligand binding detected in the absence of competitor, was determined (Fig. 4A) . The EC50s in our experiments were <8 nM for thrombospondin, approximately 60 nM for fibrinogen, and >220 nM for fibronectin. This indicates a higher potency of unlabeled thrombospondin when compared with that of fibronectin and fibrinogen in inhibiting binding of the radioligand. The most extensive binding inhibition, however, was observed with heparin: 1.5 ,ug of heparin per ml (0.26 IU/ml) inhibited 94.1% of the binding of radiolabeled thrombospondin. As a negative control, IgG had no effect on binding, even in 150-fold molar excess. In another approach, we determined the reversibility of the binding reaction. Radiolabeled thrombospondin was allowed to bind to S. aureus Cowan 1, bacteria were washed, and subsequently a 100-fold molar excess of either unlabeled thrombospondin, fibronectin, or fibrinogen or heparin (8 IU/ml) was added. Controls without added competitors were run in parallel. Binding was not reversible in the presence of fibronectin or fibrinogen, whereas unlabeled thrombospondin displaced bound thrombospondin up to approximately 60% and heparin displaced the radioligand to approximately 20% (Fig. 4B) .
Promotion of staphylococcal adherence by immobilized thrombospondin. Pretreatment of PMMA disks with soluble thrombospondin promoted adherence of various staphylococcal strains to surfaces. In Fig. SA , adherence of 3H-labeled S. aureus Cowan 1 is shown as a function of thrombospondin concentration during adsorption of the unlabeled protein to the surfaces. Adherence of S. aureus Cowan 1 to uncoated disks was <0.01% in the presence of 0.5% human serum albumin. In contrast, in the presence of albumin, adherence was significantly promoted by surfacebound thrombospondin as a function of the thrombospondin adsorbed, reaching a plateau when the thrombospondin concentration in the medium was >20 ,ug/ml. Time courses showed that adherence was optimal after 1 h of incubation (Fig. 5A, inset) . At a concentration of 25 ,ug/ml, thrombospondin promoted adherence of Cowan 1 25-fold when compared with albumin (P < 0.01, Mann-Whitney test) ( Table 2 ). The adherence-promoting potency of thrombospondin was comparable to that of laminin, significantly higher when compared with vitronectin, and significantly lower when compared with fibronectin and fibrinogen ( Table  2) .
In addition to the data obtained with selected laboratory strains, we studied binding characteristics of a variety of clinical staphylococcal strains obtained from the blood of patients with intravenous catheter infections (15) . Adherence to uncoated surfaces of S. aureus and coagulasenegative staphylococcal strains was very low (Fig. SB) . In contrast, adherence of all S. aureus strains to thrombospondin-coated disks was significantly increased (median, 60-fold; range, 12-to 91-fold [P < 0.001, Mann-Whitney test]). Adherence of a variety of the coagulase-negative strains was also increased but to a lesser extent (median, 14-fold; range, 1 to 55-fold [P < 0.001]). The S. aureus strains adhered to a significantly greater extent to surface-bound thrombospondin when compared with the coagulase-negative strains (P < 0.002, Mann-Whitney test).
Capsular typing of clinical S. aureus strains. Since the differences in adherence of the S. aureus strains may be due to definable surface characteristics, we determined the presence of two serologically different types of staphylococcal capsules. (20, 46) and a variety of clinical infections (15, 38) . In contrast to fibrinogen and fibronectin, which are abundant in plasma, plasma concentrations of thrombospondin are very low (7) and the expression in quantity at sites of platelet aggregation is absolutely dependent on platelet activation. However, thrombospondin is not only present on sites of platelet activation but is also a transient component Time (h) (B) Bloodstream isolates of S. aureus or coagulase-negative staphylococci (4 x 106 CFU/ml) were incubated with either uncoated or thrombospondin-coated (25 ,ug/ml) disks in the presence of 0.5% albumin (60 min, 37°C), and promotion of adherence was determined as described in Materials and Methods. Results are means of triplicate determinations.
of Ca2", whereas in the absence of Ca2", the capacity of the binding sites on staphylococci is significantly lower. This may be due to changes in the thrombospondin molecule or in the receptor on the bacteria or both. Thrombospondin contains a Ca2"-sensitive structure and undergoes conformational changes after the chelating of Ca2" (24) . Ca2+ has been shown to modulate a variety of thrombospondin functions, including interaction with cells (27) and other proteins (23) . The apparent Kd of 5.6 nM for thrombospondin in the presence of Ca2+ was similar when compared with values published for the binding of fibronectin and laminin to S. aureus Cowan 1 (31, 39) ; the number of thrombospondinbinding sites per microorganism was half of the number of fibronectin-binding sites on S. aureus Cowan 1 (39) and more than 20-fold larger than the number of laminin-binding sites (31) . Time courses showed that binding was maximal after 2 h of incubation, two-to fourfold longer than reported for fibronectin (39) .
Binding of radiolabeled thrombospondin to S. aureus was found to be specific, since it was inhibited by unlabeled thrombospondin to a large extent and with a high potency. Similar to results of studies with fibronectin (39) and laminin (31), binding inhibition was not complete even in the presence of high concentrations of unlabeled thrombospondin, probably due to self-association of the competitor molecules (5, 8) . Moreover, binding was inhibited by the other glycoproteins, fibronectin and fibrinogen; however, on a molar basis, these proteins were less potent in inhibiting radioligand binding when compared with unlabeled thrombospondin. Since fibronectin and fibrinogen bind to thrombospondin (22, 28) , this effect may be due to either direct interaction of these proteins with thrombospondin, competition for the same binding site, or steric hindrance by interaction with different binding sites on staphylococci. Our displacement experiments suggest that the inhibition of thrombospondin binding by fibronectin and fibrinogen is more likely to be due to steric hindrance than to competition, since in contrast to thrombospondin, binding was not reversible after the addition of excess fibronectin and fibrinogen. Heparin binds to the heparin-binding domain of thrombospondin (12, 55) , and the binding of thrombospondin to eucaryotic cells is inhibitable as well as displaceable by low doses of heparin (35 
